Impact of Patient Personality on Adherence to Oral Anticancer Medications: An Opportunity?

Five-Factor Model Type D personality cancer cancer medications chemotherapy medication adherence medication persistence oncology oral anticancer therapy

Journal

JMIR cancer
ISSN: 2369-1999
Titre abrégé: JMIR Cancer
Pays: Canada
ID NLM: 101666844

Informations de publication

Date de publication:
30 Oct 2024
Historique:
received: 16 02 2024
accepted: 31 07 2024
revised: 03 05 2024
medline: 31 10 2024
pubmed: 30 10 2024
entrez: 30 10 2024
Statut: epublish

Résumé

Adherence to prescribed oral anticancer therapy is an important determinant of patient outcomes, including progression-free and overall survival. While many factors (eg, medication side effects and out-of-pocket costs, problems with insurance authorization, and timely medication refills) can affect adherence, one that is relatively unexplored is the impact of a patient's attitude and personality. Patient personality influences medication adherence and persistence in nonmalignant chronic conditions such as cardiovascular disease and diabetes. In breast cancer and chronic myeloid leukemia, studies suggest that personality also affects adherence to oral chemotherapy which can be targeted to improve adherence. In this viewpoint, we highlight the opportunity of incorporating patient personality as interventions to oral cancer therapy adherence and discuss current barriers to implementation.

Identifiants

pubmed: 39475848
pii: v10i1e57199
doi: 10.2196/57199
doi:

Substances chimiques

Antineoplastic Agents 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e57199

Informations de copyright

©Mahtab Jafari, Alex Shahverdian, Gelareh Sadigh, Richard A Van Etten. Originally published in JMIR Cancer (https://cancer.jmir.org), 30.10.2024.

Auteurs

Mahtab Jafari (M)

Department of Pharmaceutical Scienes, University of California, Irvine, Irvine, CA, United States.

Alex Shahverdian (A)

Department of Pharmaceutical Scienes, University of California, Irvine, Irvine, CA, United States.

Gelareh Sadigh (G)

Department of Radiological Sciences, University of California, Irvine, Orange, CA, United States.

Richard A Van Etten (RA)

Department of Medicine, University of California, Irvine, Orange, CA, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH